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Olive oil in the NICU
Preterm infants exhibit an undeveloped strateum corneum, 
the structure that provides barrier function to skin. Daily 
moisturizers may restore this barrier, but such treatment 
has been suggested to increase the risk of infection. Kiechl-
Kohlendorfer and colleagues conducted a prospective study 
to evaluate the effects of topical lanolin/olive oil cream and 
Bepanthen emollient cream on the skin of 173 premature 
neonates. Treated skin showed marked improvement and a 
decreased risk of dermatitis. Treatment with olive oil cream 
was superior to treatment with emollient cream. In addi-
tion, no increased risk of infection with bacterial pathogens 
occurred in the treatment groups compared with untreat-
ed neonates. Prophylactic topical moisturizers seemingly 
improve the barrier function of the skin in preterm infants. 
(Pediatr Dermatol 25:174–8, 2008)
Invasion of cancer stem cells
Malanchi and colleagues recently reported the identification 
of cells that express CD34, a marker expressed by bulge stem 
cells, at the invading front of early and advanced epidermal 
skin tumors. This population was significantly more potent in 
initiating tumors following transplantation than cells lacking 
this marker, suggesting that bulge-derived CD34+ cells are a 
source of tumorigenesis. In addition, Wnt/β-catenin signal-
ing is involved in differentiation of skin stem cells and has 
also been implicated in human tumors. Wnt signaling was 
confirmed in the region of CD34+ cell localization. Ablation 
of β-catenin in chemically induced tumors resulted in com-
plete regression and a concomitant loss of the CD34+ pop-
ulation of cancer stem cells (CSCs). Human skin squamous 
cell carcinomas (SCCs) similarly exhibited decreased tumor 
growth when β-catenin was knocked down, indicating that 
β-catenin is essential for tumorigenesis in both murine epi-
dermal tumors and human SCCs by sustaining the CSCs that 
are essential for tumor growth. These newly characterized 
cells may serve as targets for more effective cancer therapies. 
(Nature 452:650–3, 2008)
Genome editing and cancer
The APOBEC3 family of cytidine deaminases includes nucle-
ar hA3A, hA3C, and hA3H, which are expressed in keratino-
cytes and skin. These enzymes deaminate cytidine residues in 
single-stranded DNA and exhibit antiviral effects. Vartanian 
and colleagues employed differential DNA denaturation 
PCR, which selectively amplifies AT-rich edited genomes, to 
examine the origin of replication/promoter regions of human 
papillomavirus genomes from plantar warts and precancer-
ous cervical biopsies. Indeed, this DNA exhibited significant 
editing (11% mean editing frequency for virus from plantar 
warts and 9% mean editing frequency for virus from cervi-
cal samples). Transfection experiments in human embryonic 
kidney 293T cells confirmed viral genome editing by these 
three enzymes. Because C→T transitions are predominant in 
cancer genomes, random transient overexpression of any of 
these human cytidine deaminase genes may result in gen-
eration of a mutant spectrum that ultimately leads to cancer. 
(Science 320:230–3, 2008)
Engineering autoimmunity therapy
Intravenous immunoglobulin (IVIG) is used to treat auto-
immune diseases, including rheumatoid arthritis, immune 
thrombocytopenia, and systemic lupus erythematosus. The 
anti-inflammatory effects are dependent on the terminal 
sialic acid of the N-linked glycan of the IgG Fc fragment, 
although the precise nature of the biology remains unknown. 
After identifying a preferential 2,6-linkage in IVIG prepara-
tions, Anthony and colleagues demonstrated that treatment 
with a specific 2,6-sialidase abrogated the anti-inflammatory 
activity of the IVIG preparations. In addition, IVIG-derived 
Fc fragments that had been treated with a 2,6-sialyltrans-
ferase to add sialic acids specifically at those sites reduced 
joint inflammation in an animal arthritis model. Importantly, 
a 2,6-sialylated recombinant human IgG1 Fc fragment dem-
onstrated effective anti-inflammatory activity comparable to 
that obtained with active IVIG components. This recombinant 
treatment may directly translate to development of broadly 
acting anti-inflammatory drugs to treat autoimmune diseases 
in humans. (Science 320:373–6, 2008)
Movement and polarity according to Wnt
Wnt signaling functions in a variety of biologic processes, 
including cell polarity, cell movement during develop-
ment, and cell invasion in some cancers. Because Wnt5a 
expression is correlated with high-grade, invasive human 
melanomas, Witze and colleagues probed the effects of this 
signaling powerhouse in melanoma cell lines. Treatment of 
cells with Wnt5a led to distribution of the melanoma cell 
adhesion molecule into a polarized structure (W-RAMP 
for Wnt5a-mediated receptor–actin–myosin polarity 
structure) localized to the distal end of the cell. In addi-
tion, this cell polarity was dependent on the presence of 
a CXCL12 chemokine gradient as well as on known effec-
tors of the noncanonical Wnt signaling pathway (Dvl2 and 
PKC). Overall, this mechanism involves the generation of 
an intracellular structure that integrates cell adhesion and 
cell signaling receptors with the cytoskeletal architecture in 
response to gradients of secreted factors and involves mem-
brane retraction and endosome trafficking, demonstrating 
that Wnt5a controls cell orientation, polarity, and move-
ment even in the absence of cell–cell contact. (Science 
320:365–9, 2008)
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